UK hospital trust slammed for profiting by selling drugs abroad
In the face of criticism of UK pharmacists and wholesalers for selling drugs to overseas outlets - leading to shortages of certain medicines in the UK, a British hospital, the Royal Surrey County Hospital NHS [National Health Service] Foundation Trust, which has a licence to sell drugs, has been criticized for selling more than £4 million ($6.3 million) worth of drugs abroad, making a £300,000 from the practice during the past year.
The Department of Health said trading in medicines was "unacceptable" and could lead to shortages in the UK. But the trust said it ceased the trade in January and had not sold any drugs that were in short supply. The practice was revealed in the Health Service Journal after a freedom of information request into the trust's finances.
Wholesale supplies
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze